{Reference Type}: Journal Article
{Title}: Divergent landscapes of A-to-I editing in postmortem and living human brain.
{Author}: Rodriguez de Los Santos M;Kopell BH;Buxbaum Grice A;Ganesh G;Yang A;Amini P;Liharska LE;Vornholt E;Fullard JF;Dong P;Park E;Zipkowitz S;Kaji DA;Thompson RC;Liu D;Park YJ;Cheng E;Ziafat K;Moya E;Fennessy B;Wilkins L;Silk H;Linares LM;Sullivan B;Cohen V;Kota P;Feng C;Johnson JS;Rieder MK;Scarpa J;Nadkarni GN;Wang M;Zhang B;Sklar P;Beckmann ND;Schadt EE;Roussos P;Charney AW;Breen MS;
{Journal}: Nat Commun
{Volume}: 15
{Issue}: 1
{Year}: 2024 Jun 26
{Factor}: 17.694
{DOI}: 10.1038/s41467-024-49268-z
{Abstract}: Adenosine-to-inosine (A-to-I) editing is a prevalent post-transcriptional RNA modification within the brain. Yet, most research has relied on postmortem samples, assuming it is an accurate representation of RNA biology in the living brain. We challenge this assumption by comparing A-to-I editing between postmortem and living prefrontal cortical tissues. Major differences were found, with over 70,000 A-to-I sites showing higher editing levels in postmortem tissues. Increased A-to-I editing in postmortem tissues is linked to higher ADAR and ADARB1 expression, is more pronounced in non-neuronal cells, and indicative of postmortem activation of inflammation and hypoxia. Higher A-to-I editing in living tissues marks sites that are evolutionarily preserved, synaptic, developmentally timed, and disrupted in neurological conditions. Common genetic variants were also found to differentially affect A-to-I editing levels in living versus postmortem tissues. Collectively, these discoveries offer more nuanced and accurate insights into the regulatory mechanisms of RNA editing in the human brain.